These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 1527394
1. [Effect of apomorphine on the bladder of parkinsonian patients]. Aranda B, Cramer P, Adba MA. J Urol (Paris); 1992; 98(1):25-9. PubMed ID: 1527394 [Abstract] [Full Text] [Related]
3. Effects of apomorphine and L-dopa on the parkinsonian bladder. Aranda B, Cramer P. Neurourol Urodyn; 1993; 12(3):203-9. PubMed ID: 8330043 [Abstract] [Full Text] [Related]
5. [Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease]. Pollak P, Champay AS, Gaio JM, Hommel M, Benabid AL, Perret J. Rev Neurol (Paris); 1990; 146(2):116-22. PubMed ID: 2320817 [Abstract] [Full Text] [Related]
6. Apomorphine test in de novo Parkinson's disease. Bonuccelli U, Piccini P, Del Dotto P, Pavese N, D'Antonio P, Muratorio A. Funct Neurol; 1992; 7(4):295-8. PubMed ID: 1427361 [Abstract] [Full Text] [Related]
7. [Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease]. Durif F, Deffond D, Eschalier A, Tournilhac M. Rev Neurol (Paris); 1992; 148(10):610-4. PubMed ID: 1295055 [Abstract] [Full Text] [Related]
8. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease. Happe S, Tings T, Helmschmied K, Neubert K, Wuttke W, Paulus W, Trenkwalder C. Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061 [Abstract] [Full Text] [Related]
9. Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine. Kempster PA, Lees AJ, Crichton P, Frankel JP, Shorvon P. Mov Disord; 1989 Dec; 4(1):47-52. PubMed ID: 2927402 [Abstract] [Full Text] [Related]
10. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease. Hellmann MA, Sabach T, Melamed E, Djaldetti R. Biomed Pharmacother; 2008 Dec; 62(4):250-2. PubMed ID: 17967525 [Abstract] [Full Text] [Related]
11. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Katzenschlager R, Hughes A, Evans A, Manson AJ, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees AJ. Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035 [Abstract] [Full Text] [Related]
12. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon. Uchiyama T, Sakakibara R, Hattori T, Yamanishi T. Mov Disord; 2003 May; 18(5):573-8. PubMed ID: 12722172 [Abstract] [Full Text] [Related]
13. [Subcutaneous apomorphine infusion in the treatment of Parkinson disease]. Albani C, Zangger I, Fischer G. Schweiz Rundsch Med Prax; 1992 Aug 25; 81(35):1011-5. PubMed ID: 1410978 [Abstract] [Full Text] [Related]
15. Subcutaneous apomorphine in parkinsonian on-off oscillations. Stibe CM, Lees AJ, Kempster PA, Stern GM. Lancet; 1988 Feb 20; 1(8582):403-6. PubMed ID: 2893200 [Abstract] [Full Text] [Related]
16. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease. Tison F, Wiart L, Guatterie M, Fouillet N, Lozano V, Henry P, Barat M. Mov Disord; 1996 Nov 20; 11(6):729-32. PubMed ID: 8914103 [Abstract] [Full Text] [Related]